- FDA Takes Significant Action to Help Expand Access to Testing (9/7/22)
- HIVinfo: Updates to the Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Exposed and HIV-Infected Children (9/6/22)
- NYCDOHMH: Considerations for Monkeypox Testing of Pediatric Patients (9/1/22)
- FDA Authorizes Moderna, Pfizer-BioNTech Bivalent COVID-19 Vaccines for Use as a Booster Dose (8/31/22)
- NYS EO 20.1: Continuing the Declaration of a Statewide Disaster Emergency Due to the Ongoing Spread of the Monkeypox Virus (8/28/22)
- CDC: Interim Guidance for Prevention and Treatment of Monkeypox in Persons with HIV Infection — United States, August 2022 (8/8/22)
- HIVinfo: Updates to the Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents (8/2/22)
- New: Mpox Vaccination in Adults With HIV (7/29/22)
- CDC Dear Colleague Letter: Pain Associated With Monkeypox Anogenital Lesions (7/28/22)
- NYSDOH: Monkeypox Resources for Healthcare Providers (7/26/22)